Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.

Andreakos E, Zanoni I, Galani IE.

Curr Opin Immunol. 2019 Feb;56:67-75. doi: 10.1016/j.coi.2018.10.007. Epub 2018 Nov 3. Review.

PMID:
30399529
2.

Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.

Andreakos E, Salagianni M, Galani IE, Koltsida O.

Front Immunol. 2017 Sep 29;8:1232. doi: 10.3389/fimmu.2017.01232. eCollection 2017. Review.

3.

Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation.

Chrysanthopoulou A, Kambas K, Stakos D, Mitroulis I, Mitsios A, Vidali V, Angelidou I, Bochenek M, Arelaki S, Arampatzioglou A, Galani IE, Skendros P, Couladouros EA, Konstantinides S, Andreakos E, Schäfer K, Ritis K.

J Pathol. 2017 Sep;243(1):111-122. doi: 10.1002/path.4935. Epub 2017 Aug 7.

PMID:
28678391
4.

Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.

Galani IE, Triantafyllia V, Eleminiadou EE, Koltsida O, Stavropoulos A, Manioudaki M, Thanos D, Doyle SE, Kotenko SV, Thanopoulou K, Andreakos E.

Immunity. 2017 May 16;46(5):875-890.e6. doi: 10.1016/j.immuni.2017.04.025.

5.

Type III interferons (IFNs): Emerging Master Regulators of Immunity.

Galani IE, Koltsida O, Andreakos E.

Adv Exp Med Biol. 2015;850:1-15. doi: 10.1007/978-3-319-15774-0_1. Review.

PMID:
26324342
6.

Neutrophils in viral infections: Current concepts and caveats.

Galani IE, Andreakos E.

J Leukoc Biol. 2015 Oct;98(4):557-64. doi: 10.1189/jlb.4VMR1114-555R. Epub 2015 Jul 9. Review.

PMID:
26160849
7.

CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.

Litsiou E, Semitekolou M, Galani IE, Morianos I, Tsoutsa A, Kara P, Rontogianni D, Bellenis I, Konstantinou M, Potaris K, Andreakos E, Sideras P, Zakynthinos S, Tsoumakidou M.

Am J Respir Crit Care Med. 2013 Jun 1;187(11):1194-202. doi: 10.1164/rccm.201208-1543OC.

PMID:
23525932
8.

Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation.

Salagianni M, Galani IE, Lundberg AM, Davos CH, Varela A, Gavriil A, Lyytikäinen LP, Lehtimäki T, Sigala F, Folkersen L, Gorgoulis V, Lenglet S, Montecucco F, Mach F, Hedin U, Hansson GK, Monaco C, Andreakos E.

Circulation. 2012 Aug 21;126(8):952-62. doi: 10.1161/CIRCULATIONAHA.111.067678. Epub 2012 Jul 11.

PMID:
22787112
9.

Treatment of viral conjunctivitis with antiviral drugs.

Skevaki CL, Galani IE, Pararas MV, Giannopoulou KP, Tsakris A.

Drugs. 2011 Feb 12;71(3):331-47. doi: 10.2165/11585330-000000000-00000. Review.

PMID:
21319870
10.

Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity.

Ni J, Galani IE, Cerwenka A, Schirrmacher V, Fournier P.

Vaccine. 2011 Feb 1;29(6):1185-93. doi: 10.1016/j.vaccine.2010.12.005. Epub 2010 Dec 18.

PMID:
21172381
11.

Regulatory T cells control macrophage accumulation and activation in lymphoma.

Galani IE, Wendel M, Stojanovic A, Jesiak M, Müller MM, Schellack C, Suri-Payer E, Cerwenka A.

Int J Cancer. 2010 Sep 1;127(5):1131-40. doi: 10.1002/ijc.25132.

12.

Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.

Kiessling MK, Klemke CD, Kaminski MM, Galani IE, Krammer PH, Gülow K.

Cancer Res. 2009 Mar 15;69(6):2365-74. doi: 10.1158/0008-5472.CAN-08-3221. Epub 2009 Mar 3.

13.

Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands.

Wendel M, Galani IE, Suri-Payer E, Cerwenka A.

Cancer Res. 2008 Oct 15;68(20):8437-45. doi: 10.1158/0008-5472.CAN-08-1440.

14.

Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells.

Nausch N, Galani IE, Schlecker E, Cerwenka A.

Blood. 2008 Nov 15;112(10):4080-9. doi: 10.1182/blood-2008-03-143776. Epub 2008 Aug 27.

Supplemental Content

Loading ...
Support Center